PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacology and Experimental Neuroscience, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA. cgurumurthy@unmc.edu.\', \'Mouse Genome Engineering Core Facility, Department of Pharmacology and Experimental Neuroscience, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA. cgurumurthy@unmc.edu.\', \'Mouse Genome Engineering Core Facility, Department of Pharmacology and Experimental Neuroscience, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.\', \'Sussex Neuroscience, University of Sussex, Falmer, Brighton, UK.\', \'Department of Pharmacology and Experimental Neuroscience, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.\', \'Department of Human Genetics, University of Utah, Salt Lake City, UT, USA.\', \'Division of Basic Medical Science and Molecular Medicine, Department of Molecular Life Science, School of Medicine, Tokai University, Isehara, Japan. masato@is.icc.u-tokai.ac.jp.\', \'The Institute of Medical Sciences, Tokai University, Isehara, Japan. masato@is.icc.u-tokai.ac.jp.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41596-020-00403-2
?:doi
?:hasPublicationType
?:journal
  • Nature protocols
is ?:pmid of
?:pmid
?:pmid
  • 33106680
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 8.85
?:rankingScore_hIndex
  • 189
is ?:relation_isRelatedTo_publication of
?:title
  • Genetically modified mouse models to help fight COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all